Magnetar Financial’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,884
| Closed | -$354K | – | 1236 |
|
|
2025
Q2 | $354K | Buy |
+3,884
| New | +$376K | ﹤0.01% | 648 |
|
|
2024
Q4 | – | Sell |
-165,817
| Closed | -$17.9M | – | 810 |
|
|
2024
Q3 | $17.9M | Sell |
165,817
-1,144,448
| -87% | -$125M | 0.39% | 72 |
|
|
2024
Q2 | $142M | Buy |
1,310,265
+484,816
| +59% | +$57.2M | 2.96% | 1 |
|
|
2024
Q1 | $109M | Buy |
825,449
+87,729
| +12% | +$11M | 2.44% | 3 |
|
|
2023
Q4 | $89.8M | Sell |
737,720
-358,331
| -33% | -$40M | 2.28% | 6 |
|
|
2023
Q3 | $123M | Buy |
1,096,051
+784,219
| +251% | +$99.6M | 3.14% | 2 |
|
|
2023
Q2 | $45.4M | Buy |
311,832
+307,986
| +8,008% | +$41.9M | 1% | 40 |
|
|
2023
Q1 | $497K | Buy |
+3,846
| New | +$483K | 0.01% | 460 |
|
|
2022
Q4 | – | Sell |
-16,500
| Closed | -$1.73M | – | 974 |
|
|
2022
Q3 | $1.73M | Buy |
+16,500
| New | +$1.81M | 0.02% | 617 |
|
|
2022
Q2 | – | Sell |
-41,553
| Closed | -$5.32M | – | 1842 |
|
|
2022
Q1 | $5.32M | Sell |
41,553
-38,729
| -48% | -$4.67M | 0.06% | 329 |
|
|
2021
Q4 | $9.9M | Sell |
80,282
-6,418
| -7% | -$840K | 0.1% | 216 |
|
|
2021
Q3 | $12.3M | Buy |
86,700
+81,859
| +1,691% | +$12M | 0.13% | 173 |
|
|
2021
Q2 | $756 | Sell |
4,841
-4,512
| -48% | -$731K | 0.01% | 781 |
|
|
2021
Q1 | $1.45M | Buy |
+9,353
| New | +$1.45M | 0.01% | 623 |
|
|
2020
Q2 | – | Sell |
-2,507
| Closed | -$246K | – | 596 |
|
|
2020
Q1 | $246K | Buy |
+2,507
| New | +$329K | 0.01% | 367 |
|
|
2019
Q3 | – | Sell |
-16,283
| Closed | -$1.86M | – | 595 |
|
|
2019
Q2 | $1.86M | Buy |
+16,283
| New | +$1.91M | 0.04% | 127 |
|
|
2018
Q3 | – | Sell |
-5,104
| Closed | -$552K | – | 723 |
|
|
2018
Q2 | $552K | Sell |
5,104
-4,305
| -46% | -$469K | 0.01% | 255 |
|
|
2018
Q1 | $996K | Buy |
+9,409
| New | +$1.09M | 0.02% | 202 |
|
|
2017
Q2 | – | Sell |
-3,034
| Closed | -$360K | – | 976 |
|
|
2017
Q1 | $360K | Buy |
+3,034
| New | +$344K | 0.01% | 522 |
|
|
2016
Q4 | – | Sell |
-21,625
| Closed | -$2.73M | – | 398 |
|
|
2016
Q3 | $2.73M | Buy |
21,625
+12,594
| +139% | +$1.56M | 0.04% | 144 |
|
|
2016
Q2 | $1.05M | Buy |
+9,031
| New | +$1.02M | 0.02% | 167 |
|
|
2015
Q4 | – | Sell |
-4,448
| Closed | -$406K | – | 490 |
|
|
2015
Q3 | $406K | Sell |
4,448
-1,528
| -26% | -$153K | 0.01% | 275 |
|
|
2015
Q2 | $634K | Buy |
+5,976
| New | +$661K | 0.01% | 215 |
|
Other funds holding ZBH
Magnetar Financial's ZBH Position: Q3 2025 in Review
Magnetar Financial sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 3,884 shares — an estimated $354K sold.
Magnetar Financial first reported a position in ZBH in Q2 2015 and held it in 23 quarters. The position peaked at $142M in Q2 2024. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Magnetar Financial reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
- Magnetar Financial sold 3,884 Zimmer Biomet shares in Q3 2025, an estimated $354K.
- Magnetar Financial first reported a position in Zimmer Biomet in Q2 2015 and held it in 23 quarters.
- Magnetar Financial's Zimmer Biomet position peaked at $142M in Q2 2024.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Magnetar Financial's 13F filing for Q3 2025, filed 13 Nov 2025.